Cosmos Health Inc. financial data

Symbol
COSM on Nasdaq
Location
5 Agiou Georgiou, Pilea, Thessaloniki, Greece
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99.9 % -30.4%
Quick Ratio 16.3 % -15.5%
Debt-to-equity 143 % +69.9%
Return On Equity -49.5 % +36%
Return On Assets -20.3 % +51.5%
Operating Margin -23.9 % +33.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.9M shares +95.8%
Common Stock, Shares, Outstanding 31.9M shares +37%
Entity Public Float 16.6M USD -42.5%
Common Stock, Value, Issued 32K USD +36.9%
Weighted Average Number of Shares Outstanding, Basic 30.6M shares +66.3%
Weighted Average Number of Shares Outstanding, Diluted 30.6M shares +66.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 59.8M USD +6.69%
Research and Development Expense 642K USD
Selling and Marketing Expense 143K USD -75.6%
General and Administrative Expense 12.2M USD -30.8%
Operating Income (Loss) -14.3M USD +29.3%
Nonoperating Income (Expense) -4.28M USD -1779%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.5M USD +9.07%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -12.3M USD +53.6%
Earnings Per Share, Basic 0 USD/shares +69.1%
Earnings Per Share, Diluted 0 USD/shares +69.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 889K USD
Marketable Securities, Current 33.2K USD +45.5%
Accounts Receivable, after Allowance for Credit Loss, Current 18M USD +3.12%
Inventory, Net 5.68M USD +16.3%
Assets, Current 38.1M USD +5.15%
Property, Plant and Equipment, Net 10.7M USD +0.84%
Operating Lease, Right-of-Use Asset 654K USD -8%
Intangible Assets, Net (Excluding Goodwill) 7.91M USD +2.78%
Goodwill 49.7K USD 0%
Other Assets, Noncurrent 1.22M USD
Assets 69.5M USD +7.71%
Accrued Liabilities, Current 222K USD +33.3%
Liabilities, Current 38.5M USD +52.8%
Operating Lease, Liability, Noncurrent 428K USD -8.62%
Other Liabilities, Noncurrent 1.68M USD +38.9%
Liabilities 46.4M USD +56.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 714K USD
Retained Earnings (Accumulated Deficit) -123M USD -17.7%
Stockholders' Equity Attributable to Parent 23.1M USD -33.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 26M USD -35.9%
Liabilities and Equity 69.5M USD +7.71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -186K USD +94.5%
Net Cash Provided by (Used in) Financing Activities 561K USD +171%
Net Cash Provided by (Used in) Investing Activities -7.07K USD -106%
Common Stock, Shares Authorized 1.5B shares +400%
Common Stock, Shares, Issued 32M shares +36.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 428K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.63M USD +39.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 105K USD -55.4%
Depreciation 387K USD +9.63%
Payments to Acquire Property, Plant, and Equipment 12.5K USD -84.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.4M USD +46.8%
Property, Plant and Equipment, Gross 12.5M USD +4.71%
Operating Lease, Liability, Current 225K USD -6.88%
Deferred Tax Assets, Operating Loss Carryforwards 38.5M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Operating Lease, Payments 41.1K USD +67.8%
Additional Paid in Capital 146M USD +3.93%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 887K USD +42.7%
Depreciation, Depletion and Amortization 312K USD +335%
Share-based Payment Arrangement, Expense -214K USD
Interest Expense 1.56M USD +52%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%